Concepedia

Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide®) in controlled ovarian stimulation for assisted reproduction

Mirna Stela Ludwig, R. Felberbaum, Paul Devroey, Carola Albano, H. Riethmüller-Winzen, Andreas Schüler, Werner Engel, K. Diedrich

Archives of Gynecology and Obstetrics · 2000 · 96 citations · 6 references

DOI

Concepts

References

6

Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation

Carola Albano, Johan Smitz, Michel Camus et al. · Fertility and Sterility · 1997 · 243 citations · Full text

, , +11

In vitro fertilization and the ovarian hyperstimulation syndrome

Margaret Jane MacDougall, S. L. Tan, Howard S. Jacobs · Human Reproduction · 1992 · 193 citations

, , +7

Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome

Yoram Abramov, V. Barak, Benjamin Nisman et al. · Fertility and Sterility · 1997 · 189 citations · Full text

, , +12

Risk factors and prognostic variables in the ovarian hyperstimulation syndrome

Daniel Navot, Abraham Relou, Arie Birkenfeld et al. · American Journal of Obstetrics and Gynecology · 1988 · 182 citations

, , +16

Hormone profiles under ovarian stimulation with human menopausal gonadotropin (hMG) and concomitant administration of the gonadotropin releasing hormone (GnRH)-antagonist Cetrorelix at different dosages

R. Felberbaum, Thomas Reissmann, W. Küpker et al. · Journal of Assisted Reproduction and Genetics · 1996 · 72 citations

, , +17